US-REGISTERED COMPANY 
EU WAREHOUSE
SLU-PP-332 is a synthetic ERR agonist studied in metabolic and mitochondrial models; the available findings are predominantly preclinical.
What is the research target?
SLU-PP-332 acts as an agonist of the estrogen-related receptors ERRα, ERRβ and ERRγ. These nuclear receptors participate in regulating gene expression associated with energy metabolism, fatty acid oxidation and mitochondrial function.
What do published findings show?
In mouse models of obesity and metabolic syndrome, researchers described increased energy expenditure and fatty acid oxidation, as well as less fat accumulation. These are preclinical findings; they do not establish safety or effects in humans.
PubMed: A Synthetic ERR Agonist Alleviates Metabolic Syndrome
| Element | Research context |
|---|---|
| Primary target | ERR nuclear receptors |
| Main topics | Energy metabolism, fatty acid oxidation, mitochondrial biology |
| Level of evidence | Cellular and animal models |
Related profiles
See SLU-PP-332, metabolic signalling and mitochondrial biology.
This content is intended solely for research and educational purposes. It is not medical advice or instructions for use in humans or animals.
Related catalogue and documentation
Is SLU-PP-332 a peptide?
SLU-PP-332 is a synthetic small molecule, not a peptide. Although often searched alongside research peptides, chemical structure and research area are different concepts.